ArticlePloS one2025
Machine learning-driven risk stratification for distant metastasis in gastric cancer: A comparative study of clinical features and composite indices integrated models.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveDistant metastasis (DM) of gastric cancer (GC) represents a significant health challenge due to its high mortality rates, necessitating advancements in early detection and management strategies. The objective of this study was to create a machine learning (ML) model that is interpretable for preoperative prediction of DM in GC.
methodsWe retrospectively analyzed 1,009 GC patients, of which 769 were from Zhejiang Cancer Hospital as development cohort and 240 from Zhejiang Provincial Hospital of Chinese Medicine as external test cohort. Nine clinical features, and four composite indices derived from ten laboratory indicators were selected as candidate features. The dataset was balanced using the borderline Synthetic Minority Over-sampling Technique (SMOTE) and the Edited Nearest Neighbors (ENN) under-sampling method. Univariate and multivariate analyses were used to identified key metastasis-related features. Based on the identified features, we developed predictive models incorporating five ML algorithms, with performance evaluated via receive operating characteristic (ROC) curves, recall, precision-recall (PR) curves. Ultimately, Shapley additive explanations (SHAP) analysis were applied to rank the feature importance and explain the final model.
resultsUnivariate and multivariate analyses identified five metastasis-related features: cT stage, cN stage, differentiation grade, PLR and TMI. Logistic Regression emerged as the optimal predictive model with the highest area under the curve (AUC) of 0.942 (95% CI: 0.922-0.962), Recall of 0.895 (95% CI: 0.843-0.947), and AUPRC of 0.889 (95% CI: 0.867-0.911) among five models. Additionally, the internal and external test cohorts recorded AUC values of 0.935 (95% CI: 0.897-0.972) and 0.879 (95% CI: 0.833-0.926), respectively. The SHAP analysis revealed the features that played a significant role in the predictions made by the model.
conclusionThis ML model integrates clinical features and composite indices to predict GC metastasis risk, supported by an online tool to guide preoperative decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.